Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM.

Neurology. 2007 May 22;68(21):1820-5.

PMID:
17515544
2.

Does the mitochondrial genome play a role in the etiology of Alzheimer's disease?

Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM, Howell N.

Hum Genet. 2006 Apr;119(3):241-54. Epub 2006 Jan 12.

PMID:
16408223
3.

APOA1 polymorphism influences risk for early-onset nonfamiliar AD.

Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kölsch H.

Ann Neurol. 2005 Sep;58(3):436-41.

PMID:
16130094
4.

No evidence of an association between the T16189C mtDNA variant and late onset dementia.

Gibson AM, Edwardson JA, Turnbull DM, McKeith IG, Morris CM, Chinnery PF.

J Med Genet. 2004 Jan;41(1):e7. No abstract available.

5.

Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.

Melton LM, Keith AB, Davis S, Oakley AE, Edwardson JA, Morris CM.

Glia. 2003 Oct;44(1):1-12.

PMID:
12951652
6.

Regulation of attention and response to therapy in dementia by butyrylcholinesterase.

O'Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O'Brien JT, Swan AG, Fairbairn AF, Wesnes K, del Ser T, Edwardson JA, Morris CM, McKeith IG.

Pharmacogenetics. 2003 Apr;13(4):231-9.

PMID:
12668920
7.

Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.

Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, Ballard CG, O'Brien J, Perry RH, Ince PG, Edwardson JA, Morris CM.

Dement Geriatr Cogn Disord. 2002;14(4):167-75.

PMID:
12411758
8.

The Institute for Ageing and Health, University of Newcastle, UK.

Edwardson JA, Kirkwood TB.

Exp Gerontol. 2002 Jun;37(6):749-56.

PMID:
12175475
9.

Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans.

Hussain RI, Ballard CG, Edwardson JA, Morris CM.

Neurosci Lett. 2002 Jan 4;317(1):13-6.

PMID:
11750985
10.

Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies.

Singleton AB, Gibson AM, McKeith IG, Ballard CG, Edwardson JA, Morris CM.

Neurosci Lett. 2001 Apr 27;303(1):33-6.

PMID:
11297817
11.

Multiple substrates of late-onset dementia: implications for brain protection.

Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA.

Novartis Found Symp. 2001;235:49-60; discussion 60-5. Review.

PMID:
11280033
12.

Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease.

Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, Edwardson JA, Ballard CG.

Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):327-35.

PMID:
11044778
13.

Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies.

Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, McKeith IG, Perry RH, Edwardson JA, Turnbull DM.

Neurology. 2000 Jul 25;55(2):302-4.

PMID:
10908912
14.

Brain oestradiol and testosterone levels in Alzheimer's disease.

Twist SJ, Taylor GA, Weddell A, Weightman DR, Edwardson JA, Morris CM.

Neurosci Lett. 2000 May 26;286(1):1-4.

PMID:
10822138
15.

Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry.

Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA.

Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):66-9.

PMID:
10705162
16.

Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD.

Gibson AM, Singleton AB, Smith G, Woodward R, McKeith IG, Perry RH, Ince PG, Ballard CG, Edwardson JA, Morris CM.

Neurology. 2000 Jan 25;54(2):433-8.

PMID:
10668708
17.

Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03.

Neill D, Curran MD, Middleton D, Mawhinney H, Edwardson JA, McKeith I, Ballard C, Morris C, Ince P, Jaros E, Perry R.

Neurosci Lett. 1999 Nov 12;275(2):137-40.

PMID:
10568518
18.

Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies.

Singleton AB, Gibson AM, McKeith IG, Ballard CA, Perry RH, Ince PG, Edwardson JA, Morris CM.

Neuroreport. 1999 May 14;10(7):1507-10.

PMID:
10380971
19.

CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.

Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AF, Edwardson JA, Daly AK, Morris CM.

Pharmacogenetics. 1999 Feb;9(1):31-5.

PMID:
10208640
20.

Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease.

Middleton D, Mawhinney H, Curran MD, Edwardson JA, Perry R, McKeith I, Morris C, Ince PG, Neill D.

Neurosci Lett. 1999 Mar 5;262(2):140-2.

PMID:
10203251
21.

Validation of Norwegian death certificates on dementia in residents of nursing homes.

Bjertness E, Torvik A, Ince PG, Edwardson JA.

Epidemiology. 1998 Sep;9(5):584-6. No abstract available.

PMID:
9730045
22.

LRP gene and late-onset Alzheimer's disease.

Woodward R, Singleton AB, Gibson AM, Edwardson JA, Morris CM.

Lancet. 1998 Jul 18;352(9123):239-40. No abstract available.

PMID:
9683245
23.

Butyrylcholinesterase K: an association with dementia with Lewy bodies.

Singleton AB, Gibson AM, Edwardson JA, McKeith IG, Morris CM.

Lancet. 1998 Jun 13;351(9118):1818. No abstract available.

PMID:
9635987
24.

Gastrointestinal absorption of aluminium and citrate in man.

Taylor GA, Moore PB, Ferrier IN, Tyrer SP, Edwardson JA.

J Inorg Biochem. 1998 Feb 15;69(3):165-9.

PMID:
9629675
25.

No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.

Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM.

Hum Mol Genet. 1998 May;7(5):937-9.

PMID:
9536100
26.

Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.

Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM.

Neurology. 1998 Feb;50(2):388-91.

PMID:
9484359
27.

Gastrointestinal absorption of aluminum is increased in Down's syndrome.

Moore PB, Edwardson JA, Ferrier IN, Taylor GA, Lett D, Tyrer SP, Day JP, King SJ, Lilley JS.

Biol Psychiatry. 1997 Feb 15;41(4):488-92.

PMID:
9034543
28.

Effect of aluminium on expression and processing of amyloid precursor protein.

Neill D, Leake A, Hughes D, Keith AB, Taylor GA, Allsop D, Rima BK, Morris C, Candy JM, Edwardson JA.

J Neurosci Res. 1996 Nov 15;46(4):395-403.

PMID:
8950699
29.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH.

Neurology. 1996 Nov;47(5):1113-24. Review.

PMID:
8909416
30.

Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort.

Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Edwardson JA, Torvik A, Morris CM, Bjertness E.

Neurodegeneration. 1996 Mar;5(1):43-7.

PMID:
8731381
31.

Content of brain aluminum is not elevated in Alzheimer disease.

Bjertness E, Candy JM, Torvik A, Ince P, McArthur F, Taylor GA, Johansen SW, Alexander J, Grønnesby JK, Bakketeig LS, Edwardson JA.

Alzheimer Dis Assoc Disord. 1996 Fall;10(3):171-4.

PMID:
8876778
32.

Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.

Morris CM, Massey HM, Benjamin R, Leake A, Broadbent C, Griffiths M, Lamb H, Brown A, Ince PG, Tyrer S, Thompson P, McKeith IG, Edwardson JA, Perry RH, Perry EK.

J Neural Transm Suppl. 1996;47:205-18.

PMID:
8841967
33.

Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease.

Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, Morris CM.

Neurodegeneration. 1995 Dec;4(4):443-8.

PMID:
8846238
34.

Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.

Morris CM, Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Torvik A, Bjertness E, Edwardson JA.

Neurosci Lett. 1995 Dec 1;201(1):45-7.

PMID:
8830309
35.

Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England.

Taylor GA, Newens AJ, Edwardson JA, Kay DW, Forster DP.

J Epidemiol Community Health. 1995 Jun;49(3):323-4. No abstract available.

36.

Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England.

Forster DP, Newens AJ, Kay DW, Edwardson JA.

J Epidemiol Community Health. 1995 Jun;49(3):253-8.

37.

Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions.

Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA.

Dementia. 1995 May-Jun;6(3):162-8.

PMID:
7620529
38.

Iron histochemistry of the substantia nigra in Parkinson's disease.

Morris CM, Edwardson JA.

Neurodegeneration. 1994 Dec;3(4):277-82.

PMID:
7842298
39.

Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.

Morris CM, Kerwin JM, Edwardson JA.

Neurodegeneration. 1994 Dec;3(4):267-75.

PMID:
7842297
40.

Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research.

Neill D, Hughes D, Edwardson JA, Rima BK, Allsop D.

J Neurosci Res. 1994 Nov 1;39(4):482-93.

PMID:
7884825
41.

Transferrin receptors in the normal human hippocampus and in Alzheimer's disease.

Morris CM, Candy JM, Kerwin JM, Edwardson JA.

Neuropathol Appl Neurobiol. 1994 Oct;20(5):473-7.

PMID:
7845533
42.

Transferrin receptors in the parkinsonian midbrain.

Morris CM, Candy JM, Omar S, Bloxham CA, Edwardson JA.

Neuropathol Appl Neurobiol. 1994 Oct;20(5):468-72.

PMID:
7845532
43.

Protective effect of apoE epsilon 2 in Alzheimer's disease.

Benjamin R, Leake A, McArthur FK, Ince PG, Candy JM, Edwardson JA, Morris CM, Bjertness E.

Lancet. 1994 Aug 13;344(8920):473. No abstract available.

PMID:
7914580
44.

Apolipoprotein E genes in Lewy body and Parkinson's disease.

Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM.

Lancet. 1994 Jun 18;343(8912):1565. No abstract available.

PMID:
7911882
45.

Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.

Harrington CR, Wischik CM, McArthur FK, Taylor GA, Edwardson JA, Candy JM.

Lancet. 1994 Apr 23;343(8904):993-7.

PMID:
7909090
46.

Effect of silicon on gastrointestinal absorption of aluminium.

Edwardson JA, Moore PB, Ferrier IN, Lilley JS, Newton GW, Barker J, Templar J, Day JP.

Lancet. 1993 Jul 24;342(8865):211-2.

PMID:
8100932
47.

Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus.

Perry EK, Court JA, Johnson M, Smith CJ, James V, Cheng AV, Kerwin JM, Morris CM, Piggott MA, Edwardson JA, et al.

Hippocampus. 1993 Jul;3(3):307-15.

PMID:
8394772
48.

Amorphous aluminosilicates promote nucleation of amyloid beta protein and tachykinins.

Candy JM, Oakley AE, Edwardson JA.

Biochem Soc Trans. 1993 Feb;21(1):53S. No abstract available.

PMID:
8449336
49.

Evidence for the localization of haemopexin immunoreactivity in neurones in the human brain.

Morris CM, Candy JM, Edwardson JA, Bloxham CA, Smith A.

Neurosci Lett. 1993 Jan 12;149(2):141-4.

PMID:
8474687
50.

Germanium-68 as a possible marker for silicon transport in rat brain.

Taylor GA, Pullen RG, Keith AB, Edwardson JA.

Neurochem Res. 1992 Dec;17(12):1181-5.

PMID:
1461365

Supplemental Content

Loading ...
Support Center